R, R., H, L., T, S., H, Z., A, Z., H, G., . . . J, L. (2025). Efficacy and safety of JMT103 in patients with bone metastases from solid tumors: A randomized Phase Ib clinical trial. International journal of cancer, 156(11), 2178. https://doi.org/10.1002/ijc.35343
Chicago Style (17th ed.) CitationR, Ran, et al. "Efficacy and Safety of JMT103 in Patients with Bone Metastases from Solid Tumors: A Randomized Phase Ib Clinical Trial." International Journal of Cancer 156, no. 11 (2025): 2178. https://doi.org/10.1002/ijc.35343.
MLA (9th ed.) CitationR, Ran, et al. "Efficacy and Safety of JMT103 in Patients with Bone Metastases from Solid Tumors: A Randomized Phase Ib Clinical Trial." International Journal of Cancer, vol. 156, no. 11, 2025, p. 2178, https://doi.org/10.1002/ijc.35343.